Searched for
SHANTHA BIOLOGICS
Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...- Why it is not that easy for other vaccine makers to just start producing CovaxinExplaining the need for a BSL-3 facility to make Covaxin, Dr Rakesh K Mishra, former director and now advisor of Centre for Cellular and Mo...
- Vaccine capital: Spotlight on Hyderabad; city set to produce a third of the world's dosageBe it India’s first indigenous Covid-19 vaccine candidate Covaxin or Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FluGen’s CoroFlu ...
- Advent to buy majority stake in Bharat SerumsUS-based private equity fund Advent International has signed a definitive agreement to acquire a majority stake in Bharat Serums and Vaccin...
- Advent set to buy controlling stake in Bharat SerumKotak PE and OrbiMed together that hold 23% stake in Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) are exiting through th...
- Advent International emerges sole bidder for Bharat SerumsKotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.
- Carlyle-Zydus and Advent join race to acquire Bharat Serums and Vaccines LtdThey are up against domestic pharma companies Dr Reddy's Labs, Mankind & Goldman Sachs which have also made offers.
- Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.
- Meet the women who are changing the world"Rashmi Daga is a game-changer in the food delivery app segment. It often happens that restaurants think only numbers while scaling up. Dag...
- Financial support for vaccination in India till 2020: GaviIt was formed in 2000 and between 2000 and 2015 it has immunised half-a-billion children and prevented more then 7 million deaths.
- GlaxoSmithKline Biologicals in talks to buy BE's vaccine divisionThis division produces and markets a range of paediatric and adult vaccines and has a sizeable market share in the Indian vaccine market.
- Piramal Health: No immediate gains seen from Syntech dealPiramal Healthcare has announced plans to acquire assets of Canada-based BioSyntech for around Rs 17.48 crore.
- Government leaves vaccine space for private companiesThe government has decided not to revive the four state-owned vaccine units whose licences were recently suspended.
- GMPs may take toll on drug exportsIn what could hit the country’s vaccine exports estimated to be at Rs 1,500 crore, besides maligning the reputation of Indian companies, WH...
- Biotech generics may get to tap US in shorter timeIn a development that could substantially benefit Indian companies, the US is moving closer to opening up the world’s largest pharmaceutica...
- French Merieux picks up 60% in Shantha BiotechIn a cross-border acquisition in the Indian biotech space, the E1.1-bn French major, Merieux Alliance, has snapped up a 60% stake in Hydera...
- Merieux picks up 60% in Shantha BiotecnicsFrench healthcare company Merieux Alliance on Thursday said it has picked up about 60 per cent stake in Hyderabad-based bio-pharmaceutical ...
- LVPs can be produced under loan licenceThe government has cleared a proposal to allow manufacture of large volume parenterals under loan licences.
Load More
